Literature DB >> 9316392

Proteasome inhibitors and antigen presentation.

M Bogyo1, M Gaczynska, H L Ploegh.   

Abstract

Protein degradation plays an important role in the control and regulation of many crucial biological functions, ranging from cell cycle progression to presentation of viral antigens for scrutiny by cells of the immune system. At the heart of many of these catabolic events is the multicatalytic proteinase complex known as the proteasome. This large barrel-shaped protein complex executes a remarkable set of functions ranging from the complete destruction of abnormal and misfolded proteins to the specific proteolytic activation of crucial signaling molecules. Inhibitors of this proteolytic complex have thus been extremely useful for perturbing its function and deciphering its role in these diverse biological processes. Inhibitors of the proteasome consist mainly of peptides that are modified at the predicted site of hydrolysis with a reactive functional group capable of modifying the attacking nucleophile, either reversibly or irreversibly. Many of these inhibitors can be used in living cells and have proved to be invaluable tools for the study of proteasome function.

Mesh:

Substances:

Year:  1997        PMID: 9316392     DOI: 10.1002/(SICI)1097-0282(1997)43:4<269::AID-BIP2>3.0.CO;2-T

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  9 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step.

Authors:  Mark G Delboy; Devin G Roller; Anthony V Nicola
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

3.  Inhibition of hepatitis B virus replication by interferon requires proteasome activity.

Authors:  Michael D Robek; Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 4.  The 26S proteasome complex: an attractive target for cancer therapy.

Authors:  Sarah Frankland-Searby; Sukesh R Bhaumik
Journal:  Biochim Biophys Acta       Date:  2011-10-18

Review 5.  The proteasome: a novel target for anticancer therapy.

Authors:  C Montagut; A Rovira; J Albanell
Journal:  Clin Transl Oncol       Date:  2006-05       Impact factor: 3.405

6.  Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.

Authors:  Nupur T Pande; Colin Powers; Kwangseog Ahn; Klaus Früh
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 7.  Activity-based probes as a tool for functional proteomic analysis of proteases.

Authors:  Marko Fonović; Matthew Bogyo
Journal:  Expert Rev Proteomics       Date:  2008-10       Impact factor: 3.940

8.  Intracellular localization of proteasomal degradation of a viral antigen.

Authors:  L C Antón; U Schubert; I Bacík; M F Princiotta; P A Wearsch; J Gibbs; P M Day; C Realini; M C Rechsteiner; J R Bennink; J W Yewdell
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

Review 9.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.

Authors:  David J Sherman; Jing Li
Journal:  Molecules       Date:  2020-02-05       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.